A recent analysis of the PEXIVAS trial showed that plasma exchange can significantly improve kidney function in patients with AAV and kidney involvement.
Concizumab-mtci works by inhibiting the tissue factor pathway inhibitor. This, in turn, enhances thrombin production and improves blood clotting. Concizumab-mtci (Alhemo ®) is the first subcutaneous ...
A droplet digital PCR assay for fetal blood group and platelet antigen genotyping achieved a 98.4% success rate in a real-world clinical setting. A droplet digital polymerase chain reaction assay for ...
After some stumbles out of the gate, an experimental treatment that’s part of a group hoping to be the next big thing for people with multiple sclerosis (MS) is a step closer to US Food and Drug ...
This study, active through 2031, continues to collect information on the effects of vosoritide treatment in children with achondroplasia, including medical and surgical interventions and quality of ...
The 4-miRNA signature decreased after aHSCT and remained low throughout the follow-up period. A distinct microRNA (miRNA) signature in the cerebrospinal fluid (CSF) of people with multiple sclerosis ...
Which of the statements below about the histology of hereditary angioedema (HAE) are correct? Select one of the options for each question, then submit your answers to see how well you scored and how ...
Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by the clonal expansion of abnormal B lymphocytes. 1 Despite significant advancements in targeted therapies like Bruton’s ...
TAK-754, an AAV8-based gene therapy, achieved transient factor VIII expression but failed to sustain long-term efficacy in patients with hemophilia A. Sustained factor VIII (FVIII) expression remains ...